2743TiP First-in-human (FIH) phase I/II study of ADCE-D01, a urokinase plasminogen activator receptor-associated protein (uPARAP)-targeted antibody-drug conjugate (ADC) carrying a topoisomerase 1 inhibitor payload, in patients with metastatic and/or unresectable soft tissue sarcoma (STS)

Journal article

Peer reviewed

P. Schoeffski, S. Bauer, J-Y. Blay, R.G. Maki, S. Patel, J.C. Trent, B. Wilky, M.A. Wibroe and L.H. Ottesen

Annals of oncology, Vol.36, p.S1457

2025-09

Metrics

1 Record Views

Title: 2743TiP First-in-human (FIH) phase I/II study of ADCE-D01, a urokinase plasminogen activator receptor-associated protein (uPARAP)-targeted antibody-drug conjugate (ADC) carrying a topoisomerase 1 inhibitor payload, in patients with metastatic and/or unresectable soft tissue sarcoma (STS)
Creators: P. Schoeffski
S. Bauer
J-Y. Blay
R.G. Maki
S. Patel
J.C. Trent
B. Wilky
M.A. Wibroe
L.H. Ottesen
Publication Details: Annals of oncology, Vol.36, p.S1457
Publisher: ELSEVIER; AMSTERDAM
Number of pages: 1
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991032861108202976